Canna Law Blog
AUGUST 31, 2023
This means that the country’s top health agency has finally conceded that cannabis has medical value, and isn’t a drug of abuse on par with fentanyl or heroin. As an HHS spokesperson explained: “While HHS’s scientific and medical evaluation is binding on DEA, the scheduling recommendation is not. I could go on.
Cannabis Law Report
JANUARY 30, 2019
To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. The Food and Drug Administration (FDA) recently approved Epidiolex, whose main active ingredient is CBD.
Cannabis Law Report
MARCH 25, 2019
The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). HHS, through the Food and Drug Administration, conducts an assessment and returns a recommendation to the Attorney General “in a timely manner.”.
Expert insights. Personalized for you.
115 
Let's personalize your content